Walleye Capital LLC Iovance Biotherapeutics, Inc. Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$7.78 - $14.19 $328,316 - $598,818	-42,200 Reduced 59.6%	28,600 $229,000
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $511,566 - $1.18 Million	67,400 Added 1982.35%	70,800 $1.05 Million
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $5,280 - $14,224	-1,600 Reduced 32.0%	3,400 $27,000
Q3 2023 Nov 14, 2023	SELL	$4.44 - $8.79 $83,028 - $164,372	-18,700 Reduced 78.9%	5,000 $22,000
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $127,032 - $214,722	23,700 New	23,700 $166,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.